Related Experiment Video
Updated: Jul 25, 2025

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure
Published on: May 27, 2022
Invasive Aspergillosis and the Impact of Azole-resistance
Davide Bosetti1, Dionysios Neofytos1
1Division of Infectious Diseases, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, Geneva, Switzerland.
Purpose Of Review:
IA (invasive aspergillosis) caused by azole-resistant strains has been associated with higher clinical burden and mortality rates. We review the current epidemiology, diagnostic, and therapeutic strategies of this clinical entity, with a special focus on patients with hematologic malignancies.
Recent Findings:
There is an increase of azole resistance in Aspergillus spp. worldwide, probably due to environmental pressure and the increase of long-term azole prophylaxis and treatment in immunocompromised patients (e.g., in hematopoietic stem cell transplant recipients). The therapeutic approaches are challenging, due to multidrug-resistant strains, drug interactions, side effects, and patient-related conditions.
Summary:
Rapid recognition of resistant Aspergillus spp. strains is fundamental to initiate an appropriate antifungal regimen, above all for allogeneic hematopoietic cell transplantation recipients. Clearly, more studies are needed in order to better understand the resistance mechanisms and optimize the diagnostic methods to identify Aspergillus spp. resistance to the existing antifungal agents/classes. More data on the susceptibility profile of Aspergillus spp. against the new classes of antifungal agents may allow for better treatment options and improved clinical outcomes in the coming years. In the meantime, continuous surveillance studies to monitor the prevalence of environmental and patient prevalence of azole resistance among Aspergillus spp. is absolutely crucial.
Insights
Azole-resistant invasive aspergillosis presents significant challenges, particularly for immunocompromised patients. Early detection and novel therapeutic strategies are crucial for improving outcomes in this growing clinical concern.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Hematology
Background:
- Invasive aspergillosis (IA) caused by azole-resistant strains is linked to increased morbidity and mortality.
- Azole resistance in Aspergillus species is rising globally, driven by environmental factors and extensive azole use in prophylaxis and treatment.
Purpose of the Study:
- To review the current epidemiology, diagnostics, and therapeutics of azole-resistant IA.
- To focus on the clinical entity in patients with hematologic malignancies.
Main Methods:
- Literature review of current epidemiological data.
- Analysis of diagnostic strategies for azole-resistant Aspergillus.
- Evaluation of therapeutic approaches for invasive aspergillosis.
Main Results:
- Azole resistance in Aspergillus is increasing worldwide.
- Therapeutic options are complicated by multidrug resistance, drug interactions, and patient factors.
- Hematopoietic stem cell transplant recipients are particularly vulnerable.
Conclusions:
- Rapid identification of resistant strains is critical for timely antifungal treatment, especially in allogeneic hematopoietic cell transplantation.
- Further research is needed to understand resistance mechanisms and optimize diagnostics.
- Ongoing surveillance and susceptibility profiling against new antifungal agents are essential for improved clinical outcomes.
Related Concept Videos
Fungal Phylum Ascomycota
Fungal Group Zygomycota
Fungal Phylum Microsporidia

